Key statistics
On Wednesday, GlucoTrack Inc (GCTK:NAQ) closed at 1.79, 17.52% above the 52 week low of 1.52 set on Feb 06, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.74 |
|---|---|
| High | 1.86 |
| Low | 1.73 |
| Bid | 1.61 |
| Offer | 1.83 |
| Previous close | 1.79 |
| Average volume | 1.60m |
|---|---|
| Shares outstanding | 910.69k |
| Free float | 858.95k |
| P/E (TTM) | -- |
| Market cap | 1.63m USD |
| EPS (TTM) | -1,225.32 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
More ▼
Announcements
- Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
- Glucotrack, Inc. Encourages Shareholders to Vote
- Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
- Glucotrack, Inc. Reminds Shareholders to Vote
- Glucotrack to Participate in the Q3 Virtual Investor Summit
- Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
- Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
- Glucotrack Announces Repurchase of Series A Warrants
- Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
- Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
More ▼
